Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.5M Sell
5,385
-5,031
-48% -$1.43M 0.77% 49
2025
Q1
$3.25M Hold
10,416
– – 1.73% 17
2024
Q4
$2.71M Hold
10,416
– – 1.47% 27
2024
Q3
$3.36M Buy
+10,416
New +$3.41M 1.78% 7

Other funds holding AMGN

CHB Investment Group's AMGN Position: Q2 2025 in Review

CHB Investment Group reduced its Amgen (AMGN) stake by 48% in Q2 2025, selling an estimated $1.43M and leaving 5,385 shares worth $1.5M. The position accounts for 0.77% of the portfolio, ranked #49.

CHB Investment Group first reported a position in AMGN in Q3 2024 and has held it in 4 quarters since. The position peaked at $3.36M in Q3 2024. 2,857 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • CHB Investment Group held 5,385 shares of Amgen worth $1.5M as of Q2 2025.
  • CHB Investment Group sold 5,031 Amgen shares in Q2 2025, an estimated $1.43M.
  • Amgen made up 0.77% of CHB Investment Group's portfolio in Q2 2025, its #49 holding.
  • CHB Investment Group first reported a position in Amgen in Q3 2024 and has held it in 4 quarters since.
  • CHB Investment Group's Amgen position peaked at $3.36M in Q3 2024.
  • 2,857 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on CHB Investment Group's 13F filing for Q2 2025, filed 15 Jul 2025.